Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Fresenius SE & Co. KGaA FSNUY OTC

Other OTC • Healthcare • Medical - Care Facilities • DE • USD

SharesGrow Score
53/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$9.30
-29.8%

Fresenius SE & Co. KGaA (FSNUY) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $13.25. It has a SharesGrow Score of 53/100, indicating a mixed investment profile with 1 out of 7 criteria passed.

Analyst consensus target is FSNUY = $9 (-29.8% upside).

Financials: revenue is $22.0B, -15.6%/yr average growth. Net income is $1.2B, growing at +64.6%/yr. Net profit margin is 5.5% (thin). Gross margin is 24.9% (-1.4 pp trend).

Balance sheet: total debt is $11.9B against $19.1B equity (Debt-to-Equity (D/E) ratio 0.62, moderate). Current ratio is 1.32 (adequate). Debt-to-assets is 28.8%. Total assets: $41.4B.

Analyst outlook: 1 / 1 analysts rate FSNUY as buy (100%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value 12/100 (Fail), Growth 58/100 (Partial), Past 75/100 (Partial), Health 50/100 (Partial), Moat 65/100 (Partial), Future 64/100 (Pass), Income 45/100 (Partial).

$9.30
▼ 29.81% Downside
Average Price Target
The 12-month price target for Fresenius SE & Co. KGaA is $9.30.

FSNUY SharesGrow Score Overview

53/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 12/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 75/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 65/100
Gross margin is + market cap
FUTURE 64/100
Analyst outlook — as buy
INCOME 45/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — FSNUY

✗
VALUE Fail
12/100
FSNUY trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $9, implying -32.1% from the current price $13. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
58/100
FSNUY: -15.6%/yr revenue is, +64.6%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
75/100
FSNUY: 3 / 4 years profitable. mixed. Score = 3 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
50/100
Balance sheet FSNUY: Debt-to-Equity (D/E) ratio 0.62 (moderate), Current ratio is 1.32 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
65/100
FSNUY: Gross margin is 24.9% (-1.4 pp trend), $119B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 65/100. ≥ 70 = Pass.
View details →
✓
FUTURE Pass
64/100
Analyst outlook: 1 / 1 analysts rate FSNUY as buy (100%). Analyst consensus target is $9 (-32.1% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
~
INCOME Partial
45/100
FSNUY: Net profit margin is 5.5%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range9.78-33.93
Volume2.86K
Avg Volume (30D)81.63K
Market Cap$119.41B
Beta (1Y)0.94
Dividend Yield$0.2830
Share Statistics
EPS (TTM)0.14
Shares Outstanding$9.01B
IPO Date2012-05-15
Employees175,202
CEOMichael Sen
Financial Highlights & Ratios
Revenue (TTM)$21.97B
Gross Profit$5.47B
EBITDA$3.17B
Net Income$1.21B
Operating Income$2.09B
Total Cash$1.58B
Total Debt$11.93B
Net Debt$10.34B
Total Assets$41.38B
Price / Earnings (P/E)94.6
Price / Sales (P/S)5.43
Analyst Forecast
1Y Price Target$9.30
Target High$9.30
Target Low$9.30
Upside-29.8%
Rating ConsensusBuy
Analysts Covering1
Buy 100% Hold 0% Sell 0%
Company Info
CountryDE
ExchangeOther OTC
CurrencyUSD
ISINUS35804M1053

Price Chart

Track all markets on TradingView
FSNUY
Fresenius SE & Co. KGaA ↗  ·  Other OTC
Healthcare • Medical - Care Facilities
9.78 52WK RANGE 33.93

People Also View

RMYHY
RMYHY
Ramsay Health Care Limited
$6.98
+0.00%
 MFCSF
MFCSF
Medical Facilities Corporation
$12.23
-1.48%
 MCIOF
MCIOF
MCI Onehealth Technologies Inc.
$0.55
-1.10%
 NVLPF
NVLPF
Nova Leap Health Corp.
$0.26
+0.00%
 AIH
AIH
Aesthetic Medical International Holdings Group Limited
$0.33
-33.19%
 JNHMF
JNHMF
Jack Nathan Medical Corp.
$0.01
+1,018.75%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message